NSE:SUNPHARMA Disclaimer: I am not SEBI registered person please contact your financial advisor before any investment decision.
ENTER WHERE THE MASSES HAVE THEIR STOP LOSS TRAIL TO COST WHEN REWARD IS 70% OF THE RISK TAKEN. RISK REWARD - 2:2 ALTHOUGH MARKET UNCERTAINTY IF FAR BEYOND MY ANALYSIS. GOOD LUCK TRADE AT YOUR OWN RISK!
inverted head and shoulders spotted in sun pharma pharma sector is showing positive signs nowadays so this is a good buying opportunity go long above ~518-219 target is easy 1% that is around 526 swing traders can take risk and go for a much bigger target intraday people enter wisely
Pre market price at 98.9 is above 95 resistance after covid-19 vaccine test results. Also all time high, which makes it bullish
In H4, the stock is forming price action in ascending triangle pattern. Currently is consolidating between 5.42 and 5.80. A good entry would be after it breakout from the triangle @ EP 5.86 with Support at 5.38. TP is at 6.73 and new 52WH 8.25 (Fibo 1.272) - RRR 1:1.8 EP 5.86 TP 6.73 / 8.25 SL 5.38 Stochastic shows a pullback signal, MACD didn’t signal any...
Stock has has been correcting for a while. Nifty Pharma has also been correcting and could show rebound anytime soon. Stock has taken strong support at 4800-4850 levels and has given a rebound as well. Good time to start accumulating the stock. MACD is has also given sign for reversal. 1st Target: 5330 2nd Target: 5500 SL@4700
Monthly Uptrend Weekly Uptrend Daily range with no clear TP and orientirs Trade possibe but with tight SL and speculative. Wait for formation
Will MRNA break 86.7 based on it's Covid-19 vaccine work? NOTE: Although not a recommendation, if you like my work, please donate a few coins. Thanks.
We maybe have finished movement inside this monthly downward channel, which looks like a corrective channel for previous bullish impulse. Chances are we will go north from here. But if price will brake this channel downwards it may as well become ugly, and there is no support levels, I guess? Anyway, now GILD highly tightened to SNP and thus electional uncertainty.
News looks positive for this company to produce a new vaccine for the UK, if proved safe would go global. A sound investment opportunity. Can see it rising today.
So they had a death on the vaccine research and look to be forming a head and shoulder pattern which is typical of a reversal in price, how come the news always comes so in time? the markets are so fascinating.
The pharmaceutical sector is one of the most interesting ones in such a troubled period. I see some growth potential for $ACAD in the short term. It is showing a positive trend that is already consolidated and heading for a possible TP of around 44-45$ I see this level as an important resistance since it has been tested repeatedly in the past. ***As usual, not...
If it stays above the support today, a buy signal will occur for Monday.
CLOVIS maker of FDA approved Rubraca® which is a treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer whose cancer has come back and who are in response (complete or partial response) to a platinum-based chemotherapy. www.rubraca.com Sitting at a pretty interesting area right now, sure it will get some more movement soon as we are...
Weekly chart shows very bullish from march this Year, Entry @ Rs 256 march 2020, I believe BIOCON will cross 800 by next March-April-2021.
RSI Divergence on Daily Chart Window / Gap from Rs.2784 to Rs.3063 Considering Stock has closed around Rs.3050 for 2 consecutive day, any fall from hereon would cause the stock the to fall to Rs.2784 levels. Suggestion: Sell a Call at CMP 3050 / 3000 with a SL Rs.3120.